Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease (NCT07215481)
Quantitative Digitography to Evaluate the Efficacy of Image Guided Algorithmic DBS Programming
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to evaluate an automated deep brain stimulation (DBS) algorithm developed by Boston Scientific called Illumina 3D for motor symptoms in Parkinson's disease (PD). The main question it aims to answer is: Is this new automated algorithm effective for treating motor symptoms of PD. Fifteen participants are anticipated to be enrolled. Participants are individuals who recently were implanted with DBS in the subthalamic nucleus as part of their regular clinical treatment and are scheduled to have their DBS turned ON for the first time. In addition to their regular clinical visit when their DBS is turned ON by their clinician, participants are tested on DBS settings determined by Illumina 3D (an automated algorithm). Participants are tested on these different settings across different motor tasks, including walking and finger tapping, as well as answering questionnaires. The experiment is expected to last 1 or 2 days; this is not a longitudinal or long-term trial. Participants return to their usual DBS settings once they leave the clinic.
Who can join: Review the eligibility criteria below.
Location: Stanford Neuroscience Health Clinic — Stanford, California
Age range: 21 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Stanford Neuroscience Health Clinic — Stanford, California
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Parkinson's Disease (PD)
- A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease — Aliso Viejo, California
- IMPACT 360 for Parkinson's Disease — Vancouver, British Columbia
- Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease — Birmingham, Alabama
- AAV2-hAADC for Parkinson's Disease (PDCS-01) — Columbus, Ohio
- A Study of Buntanetap in Participants With PD — Birmingham, Alabama
Explore by condition: All Parkinson's Disease (PD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.